Source: Journal of the American Society of Nephrology. Conference titles: Abstracts issue journal of the american Society of Nephrology - JASN. Unidade: FM
Subjects: SISTEMA RENINA-ANGIOTENSINA, DOENÇA CRÔINICA, NEFROPATIAS, ÓXIDO NÍTRICO, HIPERTENSÃO, ANTI-INFLAMATÓRIOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELLE, Humberto et al. Renoprotective effect of pirfenidone combined with Losartan and MMF in a model of chronic progressive renal disease. Journal of the American Society of Nephrology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 ago. 2024. , 2004APA
Delle, H., Malheiros, D., Margolin, S., & Noronha, I. de L. (2004). Renoprotective effect of pirfenidone combined with Losartan and MMF in a model of chronic progressive renal disease. Journal of the American Society of Nephrology. Baltimore: Faculdade de Medicina, Universidade de São Paulo.NLM
Delle H, Malheiros D, Margolin S, Noronha I de L. Renoprotective effect of pirfenidone combined with Losartan and MMF in a model of chronic progressive renal disease. Journal of the American Society of Nephrology. 2004 ; 15 852A res. PUB430.[citado 2024 ago. 13 ]Vancouver
Delle H, Malheiros D, Margolin S, Noronha I de L. Renoprotective effect of pirfenidone combined with Losartan and MMF in a model of chronic progressive renal disease. Journal of the American Society of Nephrology. 2004 ; 15 852A res. PUB430.[citado 2024 ago. 13 ]